Coultreon Biopharma BV
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Coultreon Biopharma BV - overview
Established
2025
Location
Leuven, -, Belgium
Primary Industry
Biotechnology
About
Founded in 2025 and based in Leuven, Belgium, Coultreon Biopharma BV operates as a biopharmaceutical company that provides research and development of oral small‑molecule therapies targeting salt‑inducible kinases for autoimmune and inflammatory diseases.
Current Investors
Sofinnova Investments, Novo Holdings, Forbion
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.coultreon.com
Verticals
Manufacturing, Nanotechnology
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.